Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5512097 | International Journal of Biological Macromolecules | 2017 | 35 Pages |
Abstract
Breast cancer is one of the most prevalent forms of cancer in women. The currently available treatment for breast cancer is mostly curative except when it becomes metastatic. One of the major sites for metastasis of breast cancer is the bone. Homing of the circulating tumor cells is tightly regulated including a number of factors present in the cells and their microenvironment. Runx2, a transcription factor plays an important role in osteogenesis and breast cancer mediated bone metastases. One of the recent advances in molecular therapy includes the discovery of the small, non-coding microRNAs (miRNAs) and they target specific genes to reduce their expression at the post-transcriptional level. This review provides an outline of breast cancer mediated bone metastasis and summarizes the recent development on the regulation of Runx2 expression by miRNAs which can lead to novel molecular therapeutics for the same.
Keywords
ECMbreast cancer geneWntPTHrPBRCTGFβRUNX2HMGA2MMPJanus kinaseJAK/STATNFκBEstrogenepithelial mesenchymal transitionHERTransforming growth factor βEMTcluster of differentiationRunt-related transcription factor 2nuclear factor kappa-Bextra cellular matrixmatrix metalloproteinaseBMPHerceptinParathyroid hormone-related proteinBone morphogenetic proteinProgesteroneRho-associated kinaseRock
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
M. Vishal, R. Swetha, G. Thejaswini, B. Arumugam, N. Selvamurugan,